Lexpos News

/Lexpos News/

MHRA Class 4 Medicines Defect Notification: Gabapentin Relonchem 50mg/ml Oral Solution (Relonchem Limited)

MHRA Class 4 Medicines Defect Notification: Gabapentin Relonchem 50mg/ml Oral Solution (Relonchem Limited) Drug alert number: EL(26)A/31 Date issued: 30 June 2026 Relonchem Limited have informed the MHRA that particles have been observed inside some bottles of Gabapentin Relonchem Oral Solution, identified through a customer complaint. DMRC reference number: DMRC- 38460232 Marketing Authorisation Holder: Relonchem [...]

The post MHRA Class 4 Medicines Defect Notification: Gabapentin Relonchem 50mg/ml Oral Solution (Relonchem Limited) appeared first on Community Pharmacy England.

By |June 30th, 2026|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Gabapentin Relonchem 50mg/ml Oral Solution (Relonchem Limited)

June 2026 Price Concessions 4th Update

The Department of Health and Social Care (DHSC) has today (30/06/2026) confirmed the following list of price concessions for June 2026: Please note: Community Pharmacy England has submitted price concession applications for other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the Department.  Drug Pack [...]

The post June 2026 Price Concessions 4th Update appeared first on Community Pharmacy England.

By |June 30th, 2026|Lexpos News|Comments Off on June 2026 Price Concessions 4th Update

MHRA Class 4 Medicines Defect Notification: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection (Brancaster Pharma Limited)

MHRA Class 4 Medicines Defect Notification: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection (Brancaster Pharma Limited) Drug alert number: EL(26)A/30 Date issued: 29 June 2026 Brancaster Pharma Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification were [...]

The post MHRA Class 4 Medicines Defect Notification: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection (Brancaster Pharma Limited) appeared first on Community Pharmacy England.

By |June 29th, 2026|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection (Brancaster Pharma Limited)

2026/27 Community Pharmacy Assurance Framework (CPAF) screening questionnaire

Pharmacy owners should soon receive confirmation from NHSBSA that the 2026/27 CPAF screening questionnaire will be available for completion from 1st July 2026 until 31st July 2026. As a result of NHS regulations introduced at the end of 2020, completion of CPAF is a requirement of the Terms of Service. Therefore, pharmacy owners must complete [...]

The post 2026/27 Community Pharmacy Assurance Framework (CPAF) screening questionnaire appeared first on Community Pharmacy England.

By |June 29th, 2026|Lexpos News|Comments Off on 2026/27 Community Pharmacy Assurance Framework (CPAF) screening questionnaire

MenB Vacc Service: PGD, resources and reminder of registration date deadline

The Patient Group Direction (PGD) for the Meningococcal B (MenB) Vaccination Service has now been published by the UK Health Security Agency. The UKHSA has also published guidance today on the vaccination programme and an associated PowerPoint slide set, which can be used to train staff that will be administering the vaccine. UKHSA guidance for [...]

The post MenB Vacc Service: PGD, resources and reminder of registration date deadline appeared first on Community Pharmacy England.

By |June 29th, 2026|Lexpos News|Comments Off on MenB Vacc Service: PGD, resources and reminder of registration date deadline